Mangalam Non Currrent Assets Other vs Cash And Short Term Investments Analysis

MANGALAM   111.48  0.15  0.13%   
Mangalam Drugs financial indicator trend analysis is infinitely more than just investigating Mangalam Drugs And recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mangalam Drugs And is a good investment. Please check the relationship between Mangalam Drugs Non Currrent Assets Other and its Cash And Short Term Investments accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mangalam Drugs And. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Non Currrent Assets Other vs Cash And Short Term Investments

Non Currrent Assets Other vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mangalam Drugs And Non Currrent Assets Other account and Cash And Short Term Investments. At this time, the significance of the direction appears to have weak contrarian relationship.
Non Currrent Assets OtherCash And Short Term InvestmentsDiversified AwayNon Currrent Assets OtherCash And Short Term InvestmentsDiversified Away100%
The correlation between Mangalam Drugs' Non Currrent Assets Other and Cash And Short Term Investments is -0.18. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Mangalam Drugs And, assuming nothing else is changed. The correlation between historical values of Mangalam Drugs' Non Currrent Assets Other and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Mangalam Drugs And are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Non Currrent Assets Other i.e., Mangalam Drugs' Non Currrent Assets Other and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

-0.18
Relationship DirectionNegative 
Relationship StrengthInsignificant

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Mangalam Drugs And balance sheet. This account contains Mangalam Drugs investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Mangalam Drugs And fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most indicators from Mangalam Drugs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mangalam Drugs And current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mangalam Drugs And. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
The current year's Selling General Administrative is expected to grow to about 471.8 M, whereas Tax Provision is projected to grow to (21.9 M).
 2022 2023 2024 2025 (projected)
Gross Profit1.2B188.1M216.3M205.5M
Total Revenue3.7B3.7B4.2B2.6B

Mangalam Drugs fundamental ratios Correlations

0.47-0.360.840.950.970.780.890.660.98-0.250.50.430.80.090.830.10.070.950.980.850.880.860.10.930.95
0.47-0.40.30.620.56-0.040.560.430.480.390.310.730.57-0.270.250.030.460.270.440.530.320.140.430.650.61
-0.36-0.4-0.36-0.27-0.42-0.41-0.29-0.22-0.38-0.53-0.16-0.24-0.15-0.18-0.310.330.03-0.41-0.34-0.23-0.3-0.21-0.32-0.3-0.29
0.840.3-0.360.750.790.720.880.530.81-0.460.420.320.740.00.960.120.060.850.840.780.810.780.050.790.81
0.950.62-0.270.750.980.60.930.680.97-0.150.470.510.86-0.090.750.080.210.810.90.890.770.80.170.970.99
0.970.56-0.420.790.980.710.910.630.99-0.120.430.470.85-0.040.770.070.180.870.910.910.780.850.180.960.98
0.78-0.04-0.410.720.60.710.580.240.76-0.310.150.080.530.370.710.1-0.260.880.760.580.640.84-0.240.60.64
0.890.56-0.290.880.930.910.580.660.9-0.270.470.480.82-0.070.880.020.130.770.850.870.750.760.10.920.94
0.660.43-0.220.530.680.630.240.660.63-0.150.750.130.440.080.66-0.120.070.590.670.490.750.40.420.630.61
0.980.48-0.380.810.970.990.760.90.63-0.190.420.390.830.010.80.070.10.90.930.890.810.890.140.940.96
-0.250.39-0.53-0.46-0.15-0.12-0.31-0.27-0.15-0.19-0.180.24-0.3-0.01-0.48-0.490.04-0.32-0.29-0.26-0.35-0.40.35-0.2-0.21
0.50.31-0.160.420.470.430.150.470.750.42-0.180.170.240.230.5-0.06-0.060.490.560.270.670.170.190.40.41
0.430.73-0.240.320.510.470.080.480.130.390.240.170.43-0.070.180.060.260.310.440.460.350.130.090.480.53
0.80.57-0.150.740.860.850.530.820.440.83-0.30.240.43-0.350.680.370.50.680.750.970.580.760.190.920.9
0.09-0.27-0.180.0-0.09-0.040.37-0.070.080.01-0.010.23-0.07-0.350.12-0.08-0.730.250.16-0.30.15-0.1-0.46-0.17-0.12
0.830.25-0.310.960.750.770.710.880.660.8-0.480.50.180.680.120.04-0.030.840.840.720.80.760.010.780.79
0.10.030.330.120.080.070.10.02-0.120.07-0.49-0.060.060.37-0.080.040.320.110.120.24-0.020.07-0.250.140.14
0.070.460.030.060.210.18-0.260.130.070.10.04-0.060.260.5-0.73-0.030.32-0.070.040.43-0.030.050.60.340.26
0.950.27-0.410.850.810.870.880.770.590.9-0.320.490.310.680.250.840.11-0.070.970.720.910.840.020.80.82
0.980.44-0.340.840.90.910.760.850.670.93-0.290.560.440.750.160.840.120.040.970.780.920.810.060.880.9
0.850.53-0.230.780.890.910.580.870.490.89-0.260.270.460.97-0.30.720.240.430.720.780.640.810.220.930.93
0.880.32-0.30.810.770.780.640.750.750.81-0.350.670.350.580.150.8-0.02-0.030.910.920.640.70.220.740.76
0.860.14-0.210.780.80.850.840.760.40.89-0.40.170.130.76-0.10.760.070.050.840.810.810.7-0.020.80.83
0.10.43-0.320.050.170.18-0.240.10.420.140.350.190.090.19-0.460.01-0.250.60.020.060.220.22-0.020.230.16
0.930.65-0.30.790.970.960.60.920.630.94-0.20.40.480.92-0.170.780.140.340.80.880.930.740.80.230.99
0.950.61-0.290.810.990.980.640.940.610.96-0.210.410.530.9-0.120.790.140.260.820.90.930.760.830.160.99
Click cells to compare fundamentals

Mangalam Drugs Account Relationship Matchups

Mangalam Drugs fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets2.6B3.3B3.6B3.3B3.8B2.1B
Short Long Term Debt Total4.8B4.2B3.6B1.1B1.2B2.2B
Other Current Liab17.6M13.9M35.2M94.0M84.6M72.1M
Total Current Liabilities1.1B1.3B1.7B1.6B1.9B2.0B
Total Stockholder Equity1.3B1.5B1.5B1.4B1.6B841.8M
Property Plant And Equipment Net1.2B1.3B1.3B1.3B1.5B884.7M
Net Debt691.1M859.6M796.1M1.1B1.2B682.2M
Retained Earnings825.1M1.0B1.0B867.3M997.4M1.0B
Cash5.9M19.5M26.8M11.9M13.7M10.3M
Non Current Assets Total1.3B1.5B1.5B1.6B1.8B950.0M
Non Currrent Assets Other26.9M24.1M8.8M928K1.1M1.0M
Cash And Short Term Investments5.9M19.5M99.9M11.9M13.7M16.9M
Net Receivables710.3M616.7M465.8M279.4M321.4M426.9M
Liabilities And Stockholders Equity2.6B3.3B3.6B3.3B3.8B2.1B
Non Current Liabilities Total242.5M477.5M423.2M338.5M304.6M273.1M
Inventory585.9M1.2B1.4B1.2B1.4B1.5B
Other Current Assets17.6M17.4M125.5M232.3M267.1M147.7M
Other Stockholder Equity1.0B223.8M228.0M332.3M382.2M446.0M
Total Liab1.3B1.8B2.1B2.0B2.3B1.2B
Total Current Assets1.3B1.8B2.1B1.8B2.0B1.1B
Accumulated Other Comprehensive Income102.5M103.6M107.9M2K2.3K2.4K
Accounts Payable426.8M545.5M970.7M661.6M760.9M426.8M
Short Term Debt596.4M575.9M567.8M885.0M1.0B525.3M
Other Liab122.9M141.8M174.3M168.1M193.3M117.7M
Net Tangible Assets978.0M1.2B1.4B1.3B1.5B973.9M
Other Assets1K63.0M(1K)434.7M1.2K1.1K
Long Term Debt68.8M3.6B187.7M133.5M120.2M114.2M
Short Long Term Debt511.8M471.0M495.7M746.0M857.9M509.9M
Property Plant Equipment961.7M1.2B1.3B11.8B13.5B14.2B
Long Term Debt Total3.5B4.2B3.7B3.0B3.4B3.3B
Intangible Assets84.7M138.8M183.0M285.2M328.0M344.4M
Current Deferred Revenue35.7M165.9M79.8M46.6M53.6M63.7M
Net Invested Capital1.9B2.2B2.2B2.2B2.6B2.1B
Net Working Capital243.4M473.6M412.3M119.4M137.3M273.2M
Capital Lease Obligations57.4M90.9M139.5M105.4M121.2M90.8M
Property Plant And Equipment Gross2.0B2.1B1.3B1.3B1.2B1.3B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Mangalam Stock

Balance Sheet is a snapshot of the financial position of Mangalam Drugs And at a specified time, usually calculated after every quarter, six months, or one year. Mangalam Drugs Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Mangalam Drugs and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Mangalam currently owns. An asset can also be divided into two categories, current and non-current.

Discover investing ideas

Utilize additional investing modules

News Freq…Investor S…